fatty acids drug
Evidence from:
primary |
all sources
Related entities (5)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| fatty acids | regulates | CYP2A6 | — | 1 |
| fatty acids | risk_factor_for | fatty liver | — | 1 |
| fatty acids | protective_against | obesity | — | 1 |
| fatty acids | interacts_with | PPARA | — | 1 |
| fatty acids | regulates | PPARα | — | 2 |
Mentioned in (12)
Papers in which this entity is mentioned.
- Prenatal alcohol exposure and white matter microstructural changes across the first 6-7 years of life: A longitudinal diffusion tensor imaging study of a South African birth cohort. (2024)
- Alcohol and Immunology: Mechanisms of multi-organ damage. Summary of the 2022 alcohol and Immunology research interest group (AIRIG) meeting. (2023)
- Central white matter integrity alterations in 2-3-year-old children following prenatal alcohol exposure. (2021)
- Macrophage Polarization States in the Tumor Microenvironment. (2021)
- Altered Maternal Plasma Fatty Acid Composition by Alcohol Consumption and Smoking during Pregnancy and Associations with Fetal Alcohol Spectrum Disorders. (2020)
- CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. (2019)
- Sex differences in associations between white matter microstructure and gonadal hormones in children and adolescents with prenatal alcohol exposure. (2017)
- A method to reduce ancestry related germline false positives in tumor only somatic variant calling. (2017)
- Detecting Genomic Signatures of Natural Selection with Principal Component Analysis: Application to the 1000 Genomes Data. (2016)
- Along-tract statistics allow for enhanced tractography analysis. (2012)
- Diffusion tensor imaging of the cerebellum and eyeblink conditioning in fetal alcohol spectrum disorder. (2011)
- Mapping white matter integrity and neurobehavioral correlates in children with fetal alcohol spectrum disorders. (2008)
Merged raw entities (15)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| fa | drug | 53 | 90 |
| fatty acids | drug | 29 | 49 |
| free fatty acids | drug | 19 | 44 |
| fatty acid | drug | 11 | 11 |
| polyunsaturated fatty acids | drug | 7 | 8 |
| fatty acid oxidation | phenotype | 6 | 7 |
| free fatty acid | drug | 6 | 7 |
| free fatty acids | phenotype | 5 | 5 |
| fatty acid transport | phenotype | 2 | 2 |
| plasma ffa | drug | 1 | 1 |
| pufas | drug | 1 | 2 |
| serum free fatty acids | drug | 1 | 3 |
| ffas | drug | — | — |
| nefa c | drug | — | — |
| released free fatty acids | drug | — | — |